Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® ...
Cidara Therapeutics (CDTX) announced it has reached full planned enrollment of 5,000 subjects in the Phase 2b NAVIGATE trial across clinical ...
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...
THE United States Agency for International Development (USAID) has partnered with the private sector for more locally accessible, stigma-free and lifesaving HIV services. The country has one of the ...
DIRECTOR General of the National Agency for the Control of AIDS (NACA), Dr Temitope llori has said that HIV infection in ...
Even though HIV is just one of a vast number of viruses that infect people, there can still be a stigma surrounding it. To break through that, experts answer some questions about the virus, such as ...
The Department of Health Western Visayas is intensifying its call for increased testing for human immunodeficiency virus (HIV ...
The new incurable disease hit all the taboos in Malaysian society as it was linked to drug use and sex. Being in the drug ...
The Royal Pharmaceutical Society (RPS) has warned about “patient safety” after discovering that draft HIV guidance directs ...
Indiana laws criminalizing human immunodeficiency virus (HIV) transmission are “outdated” and largely unnecessary, asserts a ...